Exascale Labs: ARC reports 4.95M-share holding
A 1,000,000-share sale agreement has not yet resulted in delivery; those shares remain held by ARC Group International Limited.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Exascale Labs Holdings Inc. (XLAB) is reported as having 4,946,413 Class A common shares held directly by ARC Group International Limited, its ten-percent owner, as of October 7, 2026. The same holding is also attributed indirectly to ARC Group Limited and Abraham Cinta, ARC Group’s chief executive officer and a director, who has voting and dispositive power.
The holding includes 1,000,000 shares ARC Group International Limited agreed in June 2026 to sell to Publico Partners Ltd; they remain with the holder pending delivery, and the purchase price has been received. It excludes 40,000 shares underlying private placement warrants held by the SPAC sponsor that have not been transferred.
Insights
Analyzing...
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Class A Common Stock, par value $0.0001 F1, F2 | -- | -- | -- |
| holding | Class A Common Stock, Par Value $0.0001 F1, F2 | -- | -- | -- |
Footnotes (2)
- F1. This statement is filed by ARC Group International Limited ("AGIL"), the record holder and direct beneficial owner of the shares of Class A Common Stock (the "Shares") being reported. ARC Group Limited ("ARC Group"), the parent of AGIL, and Mr. Abraham Cinta, the chief executive officer and a director of ARC Group have indirect beneficial ownership of the Shares and Mr. Cinta has voting and dispositive power of them. The address of the direct and indirect beneficial owners is c/o ARC Group International Limited, Unit 417, 4th Floor, Lippo Centre, Tower Two, No. 89 Queensway, Admiralty, Hong Kong.
- F2. Includes 1,000,000 Shares that AGIL agreed in June 2026 to sell to Publico Partners Ltd, for which AGIL has received the purchase price but which remain held by AGIL pending delivery and excludes 40,000 Shares underlying private placement warrants exercisable at $11.50 per Share, which remain held by the sponsor of the special purpose acquisition company that entered into a business combination with the Issuer, as described in a current report on Form 8-K filed by the Issuer on September 2, 2026, and have not been transferred to AGIL.
Key Figures
Key Terms
record holder regulatory
indirect beneficial ownership regulatory
voting and dispositive power regulatory
private placement warrants financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
AI-generated analysis. How Rhea-AI works. Not financial advice.